Amundi - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 211 filers reported holding BEAM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Amundi ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$159,515
-30.3%
7,1660.0%0.00%
Q2 2023$228,810
+197.5%
7,166
+173.2%
0.00%
Q1 2023$76,906
-48.6%
2,623
-28.4%
0.00%
Q4 2022$149,703
+1.2%
3,662
+25.9%
0.00%
Q3 2022$148,000
-9.2%
2,9090.0%0.00%
Q2 2022$163,000
+35.8%
2,909
+29.0%
0.00%
Q1 2022$120,000
-19.5%
2,2550.0%0.00%
Q4 2021$149,000
+79.5%
2,255
+137.1%
0.00%
Q3 2021$83,0009510.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$189,105,00091.90%
PATHWAY CAPITAL MANAGEMENT, LP 37,399$2,993,00016.59%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,390$17,960,00010.54%
HSG Holding Ltd 796,089$63,719,0004.73%
DC Investments Management, LLC 21,010$1,682,0004.17%
Monashee Investment Management LLC 268,820$21,516,0003.31%
Redmile Group, LLC 2,532,523$202,703,0002.86%
HAMILTON LANE ADVISORS LLC 98,761$7,905,0002.58%
Alphabet Inc. 640,792$51,289,0002.07%
Casdin Capital, LLC 818,820$65,538,0001.95%
View complete list of BEAM THERAPEUTICS INC shareholders